Linked Life Data

2286595

Source:http://linkedlifedata.com/resource/pubmed/id/2286595

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2286595rdf:typepubmed:Citationlld:pubmed
pubmed-article:2286595lifeskim:mentionsumls-concept:C0008677lld:lifeskim
pubmed-article:2286595lifeskim:mentionsumls-concept:C0002645lld:lifeskim
pubmed-article:2286595lifeskim:mentionsumls-concept:C0028902lld:lifeskim
pubmed-article:2286595lifeskim:mentionsumls-concept:C0055860lld:lifeskim
pubmed-article:2286595lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:2286595lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:2286595pubmed:dateCreated1991-3-26lld:pubmed
pubmed-article:2286595pubmed:abstractTextThe efficacy and safety of ofloxacin 400 mg once daily and amoxycillin/clavulanic acid 500/125 mg three times daily were compared in a double-blind manner in patients with an acute exacerbation of chronic bronchitis. Of 102 patients enrolled, 95 (93%) could be assessed for effectiveness. Treatment success was achieved in 41 (84%) of 49 patients in the ofloxacin group compared with 41 (89%) of 46 patients in the amoxycillin/clavulanic acid group. One patient who received ofloxacin and four patients in the amoxycillin/clavulanic acid group stopped medication because of unacceptable side effects. Microbiological results were evaluable in 47% of the patients. Predominant initial pathogens were Haemophilus influenzae, Streptococcus pneumoniae, sometimes in combination, and less frequently Branhamella catarrhalis. In two patients with clinical failure, randomized to ofloxacin, the initial pneumococcal strains persisted in the sputum after treatment.lld:pubmed
pubmed-article:2286595pubmed:languageenglld:pubmed
pubmed-article:2286595pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2286595pubmed:citationSubsetIMlld:pubmed
pubmed-article:2286595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2286595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2286595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2286595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2286595pubmed:statusMEDLINElld:pubmed
pubmed-article:2286595pubmed:monthNovlld:pubmed
pubmed-article:2286595pubmed:issn0305-7453lld:pubmed
pubmed-article:2286595pubmed:authorpubmed-author:VerhoefJJlld:pubmed
pubmed-article:2286595pubmed:authorpubmed-author:BeumerH MHMlld:pubmed
pubmed-article:2286595pubmed:authorpubmed-author:Rozenberg-Ars...lld:pubmed
pubmed-article:2286595pubmed:authorpubmed-author:RademakerC...lld:pubmed
pubmed-article:2286595pubmed:authorpubmed-author:HoepelmanI...lld:pubmed
pubmed-article:2286595pubmed:authorpubmed-author:MöllersM JMJlld:pubmed
pubmed-article:2286595pubmed:authorpubmed-author:SipsA PAPlld:pubmed
pubmed-article:2286595pubmed:authorpubmed-author:OverbeekB PBPlld:pubmed
pubmed-article:2286595pubmed:issnTypePrintlld:pubmed
pubmed-article:2286595pubmed:volume26 Suppl Dlld:pubmed
pubmed-article:2286595pubmed:ownerNLMlld:pubmed
pubmed-article:2286595pubmed:authorsCompleteYlld:pubmed
pubmed-article:2286595pubmed:pagination75-81lld:pubmed
pubmed-article:2286595pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2286595pubmed:meshHeadingpubmed-meshheading:2286595-...lld:pubmed
pubmed-article:2286595pubmed:meshHeadingpubmed-meshheading:2286595-...lld:pubmed
pubmed-article:2286595pubmed:meshHeadingpubmed-meshheading:2286595-...lld:pubmed
pubmed-article:2286595pubmed:meshHeadingpubmed-meshheading:2286595-...lld:pubmed
pubmed-article:2286595pubmed:meshHeadingpubmed-meshheading:2286595-...lld:pubmed
pubmed-article:2286595pubmed:meshHeadingpubmed-meshheading:2286595-...lld:pubmed
pubmed-article:2286595pubmed:meshHeadingpubmed-meshheading:2286595-...lld:pubmed
pubmed-article:2286595pubmed:meshHeadingpubmed-meshheading:2286595-...lld:pubmed
pubmed-article:2286595pubmed:meshHeadingpubmed-meshheading:2286595-...lld:pubmed
pubmed-article:2286595pubmed:meshHeadingpubmed-meshheading:2286595-...lld:pubmed
pubmed-article:2286595pubmed:year1990lld:pubmed
pubmed-article:2286595pubmed:articleTitleA double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis.lld:pubmed
pubmed-article:2286595pubmed:affiliationDepartment of Clinical Microbiology, University Hospital, Utrecht, The Netherlands.lld:pubmed
pubmed-article:2286595pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2286595pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2286595pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2286595pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:2286595pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2286595lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2286595lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2286595lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2286595lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2286595lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2286595lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2286595lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2286595lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2286595lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2286595lld:pubmed